Holder in company (NYSE: ARW) plans 2,500-share Rule 144 sale

Rhea-AI Filing Summary

A holder has filed a Rule 144 notice to potentially sell 2,500 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $388,300.00. Shares outstanding were 51,086,165 at the time referenced, which serves as a baseline figure.

The 2,500 shares were originally acquired as restricted stock vesting from the issuer, treated as compensation, across several dates from February 2022 through February 2024. The approximate date of the planned sale is February 17, 2026, and the filer represents they are not aware of undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2500	388300.00	51086165	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2022	Restricted Stock Vesting	Issuer			282	02/19/2022	Compensation
Common	02/20/2022	Restricted Stock Vesting	Issuer			52	02/20/2022	Compensation
Common	02/16/2023	Restricted Stock Vesting	Issuer			839	02/16/2023	Compensation
Common	02/19/2023	Restricted Stock Vesting	Issuer			3	02/19/2023	Compensation
Common	02/16/2024	Restricted Stock Vesting	Issuer			293	02/16/2024	Compensation
Common	02/17/2024	Restricted Stock Vesting	Issuer			123	02/17/2024	Compensation
Common	02/22/2024	Restricted Stock Vesting	Issuer			908	02/22/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transaction is disclosed in this ARW Rule 144 filing?

The filing discloses a planned sale of 2,500 shares of common stock under Rule 144. The shares may be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of February 17, 2026.

What is the value of the shares to be sold in the ARW Rule 144 notice?

The notice covers 2,500 common shares with an aggregate market value of $388,300.00. This valuation is based on the market at the time referenced and is reported directly in the Rule 144 securities information table.

How were the ARW shares being sold under Rule 144 originally acquired?

All 2,500 shares were acquired through restricted stock vesting from the issuer as compensation. Vesting occurred on several dates between February 2022 and February 2024, and each tranche is listed with its own acquisition and payment details.

On which exchange and through which broker may the ARW shares be sold?

The Rule 144 filing states that the shares may be sold on the NYSE through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. This identifies both the intended trading venue and the executing broker for the proposed transaction.

How many ARW shares were outstanding relative to the 2,500-share sale?

The filing reports 51,086,165 shares of common stock outstanding at the time referenced. This figure is provided as context for the planned 2,500-share Rule 144 sale and helps illustrate the transaction’s relative size.

What representation does the selling holder make in the ARW Rule 144 form?

By signing, the selling holder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements for such planned sales.